The American Journal of Managed Care3 小时
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
Yahoo4 小时
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
The FDA stated in a release that, "The most commonly reported side-effects of FluMist are fever over 100°F in children 2 ...
WebMD21 小时
FDA Approves First At-Home Nasal Flu Vaccine
FluMist will also continue to be available at doctors’ offices and pharmacies. For children between 2 and 17, the FDA recommends that a caregiver give the spray. Common side effects include a runny or ...
WXYZ1 小时
First self-administered, at-home flu vaccine receives FDA approval
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
healthcarepackaging9 小时
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
US FDA clears nasal flu vaccine: How safe and effective will it be?
It’s goodbye needles as you can keep the flu away with a nasal spray as the US Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist for home use. It can be self-administered by adults ...